Hereditary Testing Market
Hereditary Testing Market Size, Share & Trends Analysis Report
Hereditary Testing Market Size, Share, Statistics & Trends Analysis Report By Hereditary Cancer Testing (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Ovarian Cancer, Prostate Cancer, Stomach/Gastric Cancer, Melanoma, Sarcoma, Uterine Cancer, Pancreatic Cancer, Others), Hereditary Non-Cancer Testing (Genetic Tests, Newborn Genetic Screening, Preimplantation Genetic Diagnosis and Screening, Non-invasive Prenatal Testing (NIPT) and Carrier Screening Tests) Other Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 3011
Number of pages : 300
Published Date : Aug 2024
Category : Medical Device
Delivery Timeline : 48 hrs
Key Players
- CENTOGENE N.V. (Germany)
- Ambry Genetics (U.S.)
- Myriad Genetics, Inc. (U.S.)
- NeoGenomics Laboratories (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- PreventionGenetics (U.S.)
- Fulgent Genetics (U.S.)
- Invitae Corporation (U.S.)
- Medical Diagnostic Laboratories, L.L.C. (U.S.)
- Natera (U.S.)
- Caris Life Sciences (U.S.)
- LabSolutions (U.S.)
- Progenity Inc. (U.S.)
- ARUP Laboratories (U.S.)
Market Segmentation
Hereditary Cancer Testing
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Ovarian Cancer
- Prostate Cancer
- Stomach/Gastric Cancer
- Melanoma
- Sarcoma
- Uterine Cancer
- Pancreatic Cancer
- Others
Hereditary Non-Cancer Testing
- Genetic Tests
- Newborn Genetic Screening
- Preimplantation Genetic Diagnosis and Screening
- Non-invasive Prenatal Testing (NIPT
- Carrier Screening Test
SUMMARY
Segments
Market Segmentation
Hereditary Cancer Testing
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Ovarian Cancer
- Prostate Cancer
- Stomach/Gastric Cancer
- Melanoma
- Sarcoma
- Uterine Cancer
- Pancreatic Cancer
- Others
Hereditary Non-Cancer Testing
- Genetic Tests
- Newborn Genetic Screening
- Preimplantation Genetic Diagnosis and Screening
- Non-invasive Prenatal Testing (NIPT
- Carrier Screening Test
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- CENTOGENE N.V. (Germany)
- Ambry Genetics (U.S.)
- Myriad Genetics, Inc. (U.S.)
- NeoGenomics Laboratories (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- PreventionGenetics (U.S.)
- Fulgent Genetics (U.S.)
- Invitae Corporation (U.S.)
- Medical Diagnostic Laboratories, L.L.C. (U.S.)
- Natera (U.S.)
- Caris Life Sciences (U.S.)
- LabSolutions (U.S.)
- Progenity Inc. (U.S.)
- ARUP Laboratories (U.S.)
